SLU-PP-332
Primary recreational use: Weight loss and metabolic enhancement
What is SLU-PP-332?
SLU-PP-332 is a synthetic small-molecule compound developed at Saint Louis University, functioning as a pan-estrogen-related receptor agonist with a focus on ERRα. Primarily explored for exercise mimetic effects, it offers benefits such as weight loss, enhanced endurance, and improved insulin sensitivity without physical activity. Currently, it remains in the research phase with no FDA approval or human trials, but shows promise in preclinical studies with a good safety profile in animals. Users should be aware of the lack of human safety data, and the potential for uncharacterized effects.
Primary Benefits
Significant weight loss. Improved exercise capacity. Enhanced insulin sensitivity.
How It Works
SLU-PP-332 binds to estrogen-related receptors, predominantly ERRα, triggering the activation of oxidative metabolism and mitochondrial biogenesis pathways. This upregulates genetic expressions linked to energy metabolism, enhancing fatty acid oxidation and ATP production. As a potent exercise mimetic, it upregulates PGC-1α and activates AMPK pathways, promoting enhanced muscle oxidative capacity.
Safety Tips
Precautions reported in community discussions and literature. This is not a complete list.
- 1.DON'T use without medical supervision as it is not FDA-approved.
- 2.NEVER inject when recommended for oral use without established human protocols.
- 3.AVOID purchasing from unverified suppliers due to purity concerns.
- 4.DON'T take in combination with certain medications without consultation.
- 5.NEVER store reconstituted solutions improperly or above recommended temperatures.
Use Contexts
Different purposes have different protocols, dosing, and considerations
Metabolic enhancement and weight loss
strong evidenceSLU-PP-332 is researched for significant weight loss and improved energy expenditure without the need for physical activity.
Evidence: Studies show 12% body weight reduction and improved metabolic markers in animal models, demonstrating strong preclinical efficacy.
The following are ranges reported in published literature and community discussions. These are NOT recommendations or medical advice.
Timing: Consistent daily administration
Notes: Preclinical studies use this dosing in controlled environments only.
Community-Reported Protocols
Not recommendations: The following protocols are compiled from online communities and published literature. Pepbase does not endorse, recommend, or verify these protocols. They are provided for informational purposes only. Individual responses vary significantly. Consult a licensed medical professional before any use.
| Reported Goal | Reported Dose | Reported Frequency | Reported Route |
|---|---|---|---|
| Metabolic enhancement | 50 mg/kg | Twice daily | Intraperitoneal injection |
Pharmacokinetics
Reported Side Effects
This is not a complete list. Other side effects may occur.
Common
Serious / Rare
- Potential interactions with diabetes medications
Injection-Specific Warnings
- Use sterile DMSO for reconstitution
- Insoluble in water - ensure proper solutions
Storage
Improved exercise capacity
moderate evidenceSLU-PP-332 is studied for enhancing physical endurance and oxidative muscle functionality.
Evidence: Animal studies report up to 70% increase in exercise duration and oxidative muscle fiber development.
The following are ranges reported in published literature and community discussions. These are NOT recommendations or medical advice.
Timing: Pre-exercise administration for acute enhancement
Notes: No human protocols exist.
Community-Reported Protocols
Not recommendations: The following protocols are compiled from online communities and published literature. Pepbase does not endorse, recommend, or verify these protocols. They are provided for informational purposes only. Individual responses vary significantly. Consult a licensed medical professional before any use.
| Reported Goal | Reported Dose | Reported Frequency | Reported Route |
|---|---|---|---|
| Exercise enhancement | 50 mg/kg | Pre-exercise | Intramuscular injection |
Pharmacokinetics
Reported Side Effects
This is not a complete list. Other side effects may occur.
Common
Serious / Rare
- Potential unknown effects in human physiology
Injection-Specific Warnings
- Ensure proper dosing based on accurate body weight conversions
Storage
Harm Reduction Information
Quality Concerns
- Purity varies between suppliers—verify with COA
- Check for contaminants using laboratory assays
Safety Tips
- Use sterile DMSO for reconstitution
- Start with lowest possible dose
- Ensure solution is completely clear
- Avoid usage if planning pregnancy
Warning Signs to Stop
- Unanticipated changes in blood sugar
- Any severe allergic reactions
Seek Medical Help Immediately If
- Unexpected severe metabolic changes
- Symptoms consistent with severe diabetes complications
Frequently Asked Questions
Common questions about SLU-PP-332
How long until I see effects?
SLU-PP-332 typically shows effects within 1-2 weeks based on animal studies, but human timelines are unknown.
What time of day should I take it?
As SLU-PP-332 mimics exercise pathways, timing may not critically impact; however, splitting doses could maintain steady levels.
How can I minimize side effects?
Given SLU-PP-332's unknown human safety profile, start with low doses under professional supervision and monitor any adverse symptoms.
Does tolerance develop?
There is no current evidence of tolerance development with SLU-PP-332, but long-term human effects remain unexplored.
How should I store it?
Store DMSO stock solutions of SLU-PP-332 at -20°C (1 month) or -80°C (6 months), and avoid repeated freeze-thaw cycles.
Do I need to cycle it?
Animal studies suggest that continuous usage may be possible, but human cycling protocols have not been established.
Can I combine it with other peptides?
SLU-PP-332 may have interactions with metabolic or exercise-related compounds; professional guidance is advised.
What happens if I miss a dose?
Missing a dose of SLU-PP-332 may reduce its efficiency; resume the next scheduled dose without doubling up.
Reported Combinations
Compounds reported to be used alongside SLU-PP-332 in community discussions
Tirzepatide
Complementary metabolic effects
CJC-1295
Enhances recovery and muscle growth
NAD+
Combines mitochondrial benefits
Reported Interactions
Interactions reported in literature and community discussions.
Potential unpredictable effects on insulin sensitivity
Risk of hypoglycemia due to enhanced insulin sensitivity
Monitor metabolic responses closely
Generally safe, but monitor baseline health status
Likely safe but minimal interaction expected
Reconstitution Calculator
100 units = 1 mL
Safety Tips
- Always consult a licensed medical professional for dosing and reconstitution instructions.
- Always double check your units. Mixing up mg and mcg can be very dangerous.
- Make sure to select your syringe type. U-100 and U-50 syringes have different units.
- Ensure you're not adding more BAC than your vial can hold. Most vials have maximum capacities listed.
This calculator is for informational and educational purposes only. It does not provide medical advice, dosing recommendations, or safety determinations. Reference ranges shown are compiled from publicly available sources and are not a substitute for guidance from a licensed healthcare professional.
Legal Status by Region
Regulatory status varies by country
USA
research-only
UK
research-only
EU
research-only
Australia
research-only
Canada
research-only
Explore More Research
Browse our database of peptide research information compiled from published literature and community sources.
Citations
Last updated: October 5, 2023